Clinical Trials Logo

Toxemia clinical trials

View clinical trials related to Toxemia.

Filter by:

NCT ID: NCT05112406 Not yet recruiting - Sepsis Clinical Trials

Early Diagnostic Biomarkers of Sepsis

Start date: December 2021
Phase:
Study type: Observational

A Comparison between CRP, ferritin, and serum zinc as early diagnostic biomarkers of sepsis in critically ill patients

NCT ID: NCT05111769 Not yet recruiting - Sepsis Clinical Trials

Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

The investigators intend to conduct clinical studies to determine the efficacy of rhBNP in the treatment of septic related dysfunction and kidney dysfunction

NCT ID: NCT05107297 Not yet recruiting - Sepsis Scores Clinical Trials

Comparison to Early Detect of the Sepsis

Start date: November 1, 2021
Phase:
Study type: Observational

The aim of the study was to identify co-variates associated with 30-day mortality in septic patients admitted to the emergency department in order to improve morbidity & mortality as a sequence of sepsis in Assiut & Suez Canal Universities by comparing both scores by utilizing parameters that are readily available .

NCT ID: NCT05089760 Not yet recruiting - Neonatal Sepsis Clinical Trials

Microbiology, Antimicrobial Resistance and Outcomes of Neonatal Sepsis in China

Start date: January 1, 2024
Phase:
Study type: Observational

Neonatal sepsis remains one of the most important cause of mortality and morbidities in China. This study will establish a prospective registral cohort of all infants with culture-proven neonatal sepsis in Chinese NICUs participating in the Chinese Neonatal Network (CHNN). The microbiology, antimicrobial resistance patterns and neonatal outcomes will be described in detail for this cohort.

NCT ID: NCT04955210 Not yet recruiting - Critical Illness Clinical Trials

A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children

Start date: May 30, 2024
Phase:
Study type: Observational

1. To research the current situation of severe infection in children in China, and to investigate the incidence, prognosis and disease burden of severe infection in children in different regions of China. 2. Establish the risk prediction model and diagnosi model of severe infection in children, and verify the accuracy of the model in multi-center; 3. To study the effectiveness and safety of different treatments in real diagnosis and treatment, and to evaluate the efficacy of subgroups under different ages and high risk factors.

NCT ID: NCT04903405 Not yet recruiting - Sepsis Clinical Trials

Immune Function Monitoring and Immunotherapy in Sepsis

IMITS
Start date: June 1, 2021
Phase:
Study type: Observational [Patient Registry]

At present, the clinical studies of various anti-inflammatory drugs and immune-enhancing drugs show that immunotherapy will bring new hope for the treatment of sepsis. In order to further understand the current status of immunotherapy in China, this study aims to understand the current status and standardization of the use of sepsis immunosurveillance and immunotherapy in hospitals through a cross-sectional survey.

NCT ID: NCT04872010 Not yet recruiting - Sepsis Clinical Trials

Construction of a Database for the Life-cycle Sepsis-specific Disease Cohort

Start date: June 1, 2021
Phase:
Study type: Observational

Establish a structured clinical database for sepsis screening, and establish a special data set standard for sepsis throughout the life cycle.

NCT ID: NCT04841824 Not yet recruiting - Clinical trials for Critical Illness With or Without Sepsis

TRanscriptomic Analysis of Circulating Endothelial Cells During Sepsis - TRACES Study

TRACES
Start date: April 2021
Phase:
Study type: Observational

Vascular dysfunction is an important mechanism involved in organ failure, in the setting of sepsis condition, with different types of circulating endothelial cells.Transcriptom analysis via RNAseq in different types of circulating endothelial cells, comapring critically ill patients with or without sepsis will allow determining differential gene expression for signal pathways in endothelial alteration and restoration associated with sepsis.

NCT ID: NCT04718623 Not yet recruiting - Clinical trials for Diagnoses, Syndromes, and Conditions

Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1

Start date: February 2021
Phase:
Study type: Observational

The aim of the present work is to study: Persepsin (sCD-14) and Syndecan-1 as biomarkers following major surgeries for early diagnosis and prognosis of sepsis Primary aim: early diagnosis and prognosis of sepsis Secondary aim: correlate them with SOFA and qSOFA scores.

NCT ID: NCT04646629 Not yet recruiting - Sepsis Clinical Trials

Effect of Electroacupuncture on Sepsis-induced Intestinal Dysfunction

Start date: November 23, 2020
Phase: N/A
Study type: Interventional

1. Title: Effect of electroacupuncture on sepsis-induced intestinal dysfunction 2. Research center: single center 3. The Design of the study: Randomized, double-blind, controlled study 4. The population of the study: The patients over 18 years that met the criteria of sepsis3.0 and with AGI grade II or above are enrolled in the study 5. Sample size: Enroll 60 patients (30patients in each group) 6. Interventions: Participants in the treatment group underwent 60 minutes acupuncture (0.30mm×70mm) at ST36 (Zusanli) and ST37 (Shangjuxu) twice a day for seven days. After"Deqi",electroacupuncture stimulation apparatus (HANS G6805-2, Huayi Co, Shanghai, China) is connected and maintained the end of treatment. Participants in the control group received shallow needling (0.30mm×25mm) at ST36 and ST37(nonacupoints located 1 inch beside acupoints, about 20mm). Specifically, the depth of needle insertion into nonacupoints is 3-5mm and avoided manual stimulation and no "Deqi" without actual current output. 7. The aim of the research: To investigate the effect of electroacupuncture on sepsis-induced intestinal dysfunction. 8. Outcome# 1) Primary outcome: The intestinal function indicators including: 1) Clinical symptoms: bowel sounds, intra-abdominal pressure, time to first exhaust/defecation, daily tolerable enteral nutrition 2) Intestinal motility indicators: the levels of serum motilin and gastrin 3) Intestinal barrier indicators: the levels of serum diamine oxidase (DAO), D-lactic acid and I-FABP 2)Secondary outcome# Duration of mechanical ventilation in patients with endotracheal intubation on ICU admission; Length of stay in ICU and Length of stay in hospital; 30-day life quality and cognitive function after surgery; All-cause 28-day mortality. 9. The estimated duration of the study#1-2years.